C
Cryton develops novel small molecule therapeutics focused on restoring mitochondrial function to treat complex diseases, starting with cancer. This approach simultaneously induces immunogenic tumor death and restores the metabolic capacity of exhausted T cells for unified anti-tumor immunity. The company aims to provide new treatment options for patients facing therapy-resistant malignancies.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cryton develops novel small molecule therapeutics focused on restoring mitochondrial function to treat complex diseases, starting with cancer. This approach simultaneously induces immunogenic tumor death and restores the metabolic capacity of exhausted T cells for unified anti-tumor immunity. The company aims to provide new treatment options for patients facing therapy-resistant malignancies.